CADL - Candel Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CADL is currently covered by 3 analysts with an average price target of $13.83. This is a potential upside of $4.24 (44.21%) from yesterday's end of day stock price of $9.59.

Candel Therapeutics's activity chart (see below) currently has 2 price targets and 7 ratings on display. The stock rating distribution of CADL is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for CADL is $3, Lowest price target is $3, average price target is $13.83.

Most recent stock forecast was given by EVAN SEIGERMAN from BMO on 15-May-2023. First documented stock forecast 23-Aug-2021.

Best performing analysts who are covering CADL - Candel Therapeutics:

Evan Seigerman Judah Frommer

Currently out of the existing stock ratings of CADL, 4 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

3

$1.3 (76.47%)

18

11 months 22 days ago

0/2 (0%)

$1.4 (87.50%)

Buy

1 years 1 months 6 days ago

0/1 (0%)

$7.07 (89.16%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CADL (Candel Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on CADL (Candel Therapeutics) with a proven track record?

EVAN SEIGERMAN

Which analyst has the current lower performing score on CADL (Candel Therapeutics) with a proven track record?

JUDAH FROMMER

Which analyst has the most public recommendations on CADL (Candel Therapeutics)?

Evan Seigerman works at BMO and has 8 price targets and 5 ratings on CADL

Which analyst is the currently most bullish on CADL (Candel Therapeutics)?

Evan Seigerman with highest potential upside - $1.3

Which analyst is the currently most reserved on CADL (Candel Therapeutics)?

Judah Frommer with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?